Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:16 PM
Ignite Modification Date:
2026-03-26 @ 3:16 PM
NCT ID:
NCT07409168
Eligibility Criteria:
Inclusion Criteria:
* 1\. Age ≥ 18 years.
* 2\. Pathologically confirmed extranodal natural killer/T-cell lymphoma (NKTCL) according to the World Health Organization (WHO) classification.
* 3\. Patients who are planned to receive first-line asparaginase-based chemotherapy or chemoradiotherapy.
* 4\. Patients who have either contrast-enhanced MRI of the nasopharynx obtained as part of routine clinical care or pretreatment whole-slide images (WSI) of tumor tissue from hematoxylin and eosin (H\&E)-stained sections available for analysis.
* 5\. Ability to understand the study and provide written informed consent (ICF).
Exclusion Criteria:
* 1\. History of other malignant tumors.
* 2\. Patients with psychiatric disorders or those unable to provide informed consent.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07409168
Study Brief:
Protocol Section:
NCT07409168